Mumbai, Feb. 19 -- Based in UK, the Mercury Pharma Group is a specialty pharmaceutical company.

Progynova (estradiol valerate) is an oral hormone replacement therapy indicated for the treatment of estrogen deficiency symptoms and for the prevention of postmenopausal osteoporosis.

Cyclo Progynova (estradiol valerate and norgestrel) is a combined hormone replacement therapy indicated for the treatment of estrogen deficiency symptoms, providing both estrogen and progestogen components.

As per IQVIA MAT December 2025, the Progynova brand had recorded sales of Rs 100 crore.

The company stated that this acquisition would strengthen Dr. Reddy's gynaecology portfolio and mark its strategic entry into the hormone replacement therapy segment. ...